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ABSTRACT
Sleep disturbance affects nearly 30 percent of breast cancer survivors and has
consequences on quality of life. Pharmacologic treatment for sleep disturbance exists,
however cancer survivors are seeking alternative ways to improve outcomes. There is a
need to investigate treatment modalities for sleep disturbance and quality of life in this
population. Qigong is a five-dimension-based mind-body therapy that has shown to
improve sleep disturbance and quality of life. There has yet to be a randomized controlled
trial comparing Qigong to an active control on sleep disturbance specifically for breast
cancer survivors. We propose that Qigong will be superior in improving sleep
disturbance and quality of life in breast cancer survivors when compared to light
exercise. Participants will be randomized to either Qigong or light exercise over twelve
weeks. The findings will inform healthcare providers and assist them in managing
symptoms that may improve quality of life in this population.
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CHAPTER 1: INTRODUCTION
1.1 BACKGROUND
Breast cancer is the most commonly diagnosed cancer in females in the United
States and the second most common cause of cancer-related death in females in the United
States.1 With increasing early detection screening tools and successful treatment regimens,
higher numbers of women are diagnosed with early-stage breast cancer every year and
mortality rates are steadily declining.2,3 In developed nations, there is now a 90% 5-year
survival rate for women with breast cancer and an almost 100% 5-year survival rate for
those with localized disease.4 As of January 1, 2019, an estimated 8,781,580 female cancer
survivors were living in the United States, with 3,861,520 of those being breast cancer
survivors (BCS) specifically.4 Yet with this increase in survivorship comes an increase in
patients presenting to their healthcare providers with side effects from treatment and longterm comorbidities.4
The choice of treatment for women diagnosed with breast cancer is dependent on
cancer stage, tumor size and grade, number of involved lymph nodes, and status of hormone
receptors.5 Surgery is usually the first choice of treatment for early-stage breast cancer and
entails either breast-conserving therapy or mastectomy.6 Depending on the stage and extent
of lymph node or other organ involvement, women may undergo adjuvant therapy or
neoadjuvant therapy. Adjuvant therapy is systemic therapy using chemotherapy, endocrine
therapy, and/or targeted therapy. Women with localized and earlier-staged disease are most
likely to benefit from neoadjuvant therapy, therapy initiated before surgery; it has
demonstrated better overall disease-free survival outcomes than surgery combined with
adjuvant systemic therapy.6
1

With the treatment options available come multiple side effects including those
affecting body physiology, mental health, and quality of life. Physiological side effects can
include chronic pain, lymphedema, infertility, cognitive deficits, and cardiotoxicity.7-9
Depression, anxiety, fatigue, and sleep disturbance are particularly pervasive in this
population both during and after treatment, and are a result of a combination of the
malignancy itself, treatment, and effects of treatment.10 Women undergoing treatment may
experience depression and anxiety due to fear of recurrence, uncertainty of disease
prognosis, fears of experiencing side effects, and worry of career and financial implications
of the prognosis.7,11 One study found that 4.6% of a sample of 153 BCS met diagnostic
criteria for post-traumatic stress disorder (PTSD) related to their breast cancer treatment as
long as 20 years after diagnosis.11
Fatigue has an estimated prevalence of anywhere from 28 to 91% in cancer patients
and approximately 30% will experience persistent symptoms for years after treatment.5,12
Fatigue in cancer patients is a subjective and persistent sense of exhaustion physically,
emotionally, and/or cognitively that cannot be attributed to recent activity and is related to
cancer or cancer treatment.12 There are many treatable contributing factors to fatigue in this
population, a major one of which is sleep disturbance.12
Sleep disturbance, the focus of this study, is nearly ubiquitous in the breast cancer
population. Compared to patients with other forms of cancer, breast cancer patients tend to
experience sleep disturbance more frequently, and the majority report it within the first year
of diagnosis and treatment.13,14 In BCS, prevalence rates of sleep disturbance are estimated
to be anywhere from 30 to 90%; close to that of fatigue rates in all cancer patients.13 Almost
30% of BCS meet the criteria for insomnia which is defined as difficulty initiating sleep,
2

frequent awakenings, and an inability to return to sleep.13 This is almost twice the rate of
sleep disturbance as seen in the general population.13 The types of sleep disturbances in BCS
can vary widely and may include difficulty falling asleep, difficulty staying asleep, nonrestorative sleep, frequent nighttime awakenings, hypersomnolence, excessive daytime
napping, sleep apnea, parasomnias, restless leg syndrome, and sleep-related movement
disorders like sleepwalking.13,15,16 Untreated sleep disturbance in BCS has negative
consequences on quality of life and well-being, and has been associated with comorbidities
like hypertension.13 A 2014 study found that sleep disturbance in breast cancer patients with
metastatic disease was associated with poorer survival outcomes and that participants
reporting less objective sleep disturbance were found to have significantly lower mortality
rates over six years.17
The etiology of sleep disturbance in this population is multifactorial and not
completely understood. The stress and anxiety associated with a cancer diagnosis in
combination with the side effects of treatment are thought to be the primary precipitating
factors.17 Physiologically, chronic low-grade inflammation and altered regulation of the
autonomic nervous system have been implicated.18 The diagnosis of cancer itself has also
been shown to alter the circadian rest-activity rhythm that normally dictates the sleepwake cycle due to changes in rhythmic secretions of cortisol.18 Additionally, recent
evidence has found that sleep disturbance, fatigue, and depression tend to co-occur.16 One
study found that insomnia was related to higher levels of fatigue, with a higher degree of
insomnia predicting a higher level of fatigue.19 Because sleep disturbance is a strong
contributing factor of fatigue, and because of the intertwining nature of these disorders,
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treating sleep disturbance has implications for concurrent treatment of fatigue, anxiety, and
depression as well.
First-line treatment for sleep disturbance in BCS is usually either pharmaceutical
therapy or psychotherapy, specifically Cognitive Behavioral Therapy for Insomnia (CBTI).15 Yet many cancer survivors have an increased desire to use complementary medicine
(CM) therapies. Eighty-three percent of American cancer patients have reported the use of
CM in addition to their standard medical therapies after diagnosis, and nearly 50% of BCS
report annual use of mind-body interventions to improve their health.20,21 Exercise is an
alternative treatment modality recommended by the National Comprehensive Cancer
Network (NCCN) which has published guidelines for improvement in general sleep hygiene
measures for cancer patients.14 Exercise has been shown to improve perceived global sleep
quality in BCS and endometrial cancer survivors and has demonstrated improved outcomes
of better sleep including fatigue, physical function, and quality of life in patients with
multiple forms of cancer.14,22,23 Although the benefits of exercise are apparent, exercise is
considered a unimodal intervention and lacks multimodality unique to meditative movement
exercises such as Qigong, Tai Chi, and yoga that could have more extensive indications for
the myriad of symptoms that contribute to sleep disturbance.24
Medical Qigong is a traditional Chinese medicine practice that could serve as a CM
modality option for BCS experiencing sleep disturbance. As a form of CM, Qigong is
widely used in China in conjunction with traditional healing modalities like
pharmaceuticals or surgery, working best through this synergy.25 The practice combines
breathing, exercise, meditation, and body movements with the primary goal of manipulating
the body’s energy, or “qi,” to improve physical, psychological, and spiritual health.26,27
4

Though the exact mechanisms of Qigong remain unknown, it is thought to improve
homeostasis of the autonomic nervous system and to increase the production of endogenous
melatonin, a hormone for sleep and circadian rhythms in the body.13,21,28 Slow, deep
breathing has been implicated in reductions in oxidative stress, blood pressure, and bringing
balance to the autonomic nervous system.29 Further, the combination of breathing with
mindfulness and movement may contribute to improvement in emotional state, anxiety, and
depression.29 Tai Chi is one of the most widely known forms of Qigong especially in the
United States, but it differs from pure Qigong in that it is more choreographed and
complex, while Qigong is traditionally more repetitive, gentler, and easier to learn.29
Qigong is an accessible modality for both healthy adults and those living with
chronic disease and the benefits appear to be widespread. The exercise component of
Qigong is gentle and easy to learn, and requires less physical capacity when compared to
traditional aerobic exercise, yoga, and even Tai Chi.13 Thus, it may be more accessible to
our population who often suffer from multiple treatment effects and comorbidities, as well
as those in our population who are older and would benefit from exercise that corresponds to
age-related changes.26 Previous research has demonstrated adherence to conventional
exercise being as low as 39% in cancer patients; while in the Women’s Healthy Eating and
Living study, 70% of BCS adhered to Tai Chi or Qigong.29 Comparing the benefits of
Qigong’s multimodal framework to the unimodal framework of aerobic exercise and
exploring implications of its effects on sleep disturbance and quality of life could both add
to the knowledge of this eastern-medicine practice and give BCS a more accessible
treatment option to sustain a healthy life.

5

1.2 STATEMENT OF THE PROBLEM
Sleep disturbance is reported as a major source of distress in BCS and has
negative effects on quality of life.30 Due to sleep disturbance being a result of multiple
possible etiologies, it is difficult to identify the most effective method to manage it. CM
modalities for treating sleep disturbance are becoming more desirable to BCS. Yet
efficacy trials of alternative modalities are lacking to inform both patients and
providers.21 Exercise is a unimodal non-pharmaceutical treatment option for sleep
disturbance that has been shown to improve sleep and quality of life in BCS; however,
for BCS with multiple comorbidities and increasing age, exercise is not always accessible
and adherence may prove difficult.26,29 Qigong may be a more accessible and effective
alternative.
Because Qigong is based in Eastern medicine, some studies have lacked
generalizability as samples have been restricted to locations in Asian countries.13,27
Sample sizes of trials have been small and some studies lacked effective control groups
or the presence of control groups at all, which threaten the validity of results.13,29
Randomized controlled trials (RCT) comparing the multimodal benefits of Qigong
compared to the unimodal benefits of exercise on sleep disturbance and quality of life are
missing.29 There is a need to extend the literature with an RCT comparing Qigong with an
active control, such as light exercise, in BCS to add treatment options and improve
survivorship outcomes in this population.
1.3 GOALS AND OBJECTIVES
In this RCT, we aim to investigate the multidimensional effects of Qigong compared
to light exercise in female BCS. We will accomplish this by looking at the pre- and post6

intervention changes in five dimensions—physical, social, spiritual, emotional, and
mental—with an emphasis on the physical dimension as measured by sleep disturbance. We
hope to demonstrate the improved mind-body benefits of Qigong over conventional exercise
and add to the literature regarding the efficacy of this more accessible option for mitigation
of post-treatment sleep disturbance and decreased quality of life.
Only BCS who meet the eligibility criteria will be enrolled in the trial. Participants
will be randomly assigned to one of two groups: Qigong or light exercise. They will be
followed weekly for 12 weeks. The main objective is to determine differences in mean
change from baseline in self-reported sleep scores as measured by the Pittsburg Sleep
Quality Index (PSQI) between groups. Secondary objectives include: 1) determining
differences in mean change from baseline between groups in objective sleep parameters
using a Fitbit wristband, 2) determining differences in mean change from baseline between
groups in the four other dimensions—social, spiritual, emotional, and mental—measured by
the Functional Assessment of Cancer Therapy- Breast (FACT-B) and the spirituality
subscale of the FACT-B, the Functional Assessment of Chronic Illness Therapy- Spiritual
Well-Being Scale (FACIT-Sp).
1.4 HYPOTHESIS
Among adult females within six months to five years past completion of primary
treatment for primary breast cancer stages 0-III, there will be a statistically significant
difference in sleep disturbance measured by mean change in sleep quality scores on the
PSQI after 12 weeks of an instructor-led group Qigong course, as compared to instructorled light exercise through the integration of physical movement and meditative stress
reduction, and results will be durable 6 months after intervention completion.
7

1.5 DEFINITIONS
Primary breast cancer treatment: Surgery, radiation, chemotherapy, or endocrine
therapy.
Sleep disturbance: Difficulty initiating sleep, frequent awakenings, and an inability to
return to sleep.13 A score of greater than 5 on the PSQI.31
Medical Qigong/ Qigong: “qi” -energy flow or life energy, “gong” -achievement, work,
or skill.23,27 A movement-based mind-body practice originating in China that combines
slow, low-impact movement with meditation, breathing techniques, and mindful focus on
the body, with a goal of manipulating the body’s energy (qi) for the benefit of physical,
psychological, and spiritual health.23,27
Instructor-led light exercise: Classes led by exercise physiologists meeting at the same
length and frequency as the Qigong group with focus on light resistance training,
stretching, and a light aerobic component.
Pittsburg Sleep Quality Index (PSQI): a self-rated questionnaire that assesses sleep
quality and disturbance through nineteen individual items that generate a global score and
seven component scores.31
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CHAPTER 2: REVIEW OF THE LITERATURE
2.1 INTRODUCTION
A search of relevant medical literature was conducted between August 2019 and
June 2020 using Ovid Medline, EMBASE, PsychINFO, AMED, Cochrane, and Scopus.
Primary searches were performed using the combination of MeSH terms “breast
neoplasms,” “cancer survivors,” “Qigong,” “medicine, Chinese traditional,” “sleep,” and
“sleep initiation and maintenance disorders.” Additional search terms included Tai Chi,
Tai Ji, mind-body therapies, mind-body intervention, exercise therapy, survivors, cancer
survivors, neoplasms, Fitbit, accelerometry, quality of life, insomnia, and sleep-wake
disorders. The search was limited to articles written in English and to those with human
subjects. Articles were analyzed for relevance to the topic and clinical trials, systemic
reviews, and meta-analyses were prioritized. Additional references were extracted from
reference lists of primary articles if found to be pertinent to our study. The literature
search and review demonstrate the prevalence of sleep disturbance in breast cancer
patients undergoing treatment and the prevalence of symptoms that persist following
treatment. It is evident through the search that many alternative therapies have been
considered and studied for this issue, but there remains much to learn regarding Qigong
and its efficacy in our population.
2.2 REVIEW OF EMPIRICAL STUDIES
2.2.1 Sleep Disturbance in Female Breast Cancer Survivors
Multiple studies have demonstrated the prevalence of sleep disturbance in female
breast cancer patients both during and after treatment. One study investigated subjective
sleep disturbance in women with breast cancer stages I-III undergoing four rounds of
11

chemotherapy compared to age-matched women without cancer.1 They found that
women with breast cancer experienced worse subjective sleep quality as measured by the
PSQI than their non-cancer counterparts (p=0.011 at start of treatment T1, p<0.001 after
four cycles of chemotherapy T2, and p=0.02 one year after treatment initiation T3).1
Similarly, an observational study of women with stages I-IIIA breast cancer found that
between six months and 12 months after the start of endocrine therapy, self-reported
sleep quality with the PSQI went from poor (a score of 6-10) to very poor (a score of
≥10) (p=0.03).2 A third study found that breast cancer patients receiving cancer treatment
tended to report worse sleep (p<0.06) and experience longer sleep latency (p<0.10) than
those not receiving treatment.3 They also found that sleep disturbance was correlated with
reported deficits in quality of life including decreased ability to perform daily tasks and
feelings of low energy.3 These studies demonstrate that women experience sleep
disturbance both before the start of treatment and throughout the course of treatment.
A few studies have demonstrated that sleep disturbance can extend beyond the
completion of cancer treatment and can persist for years. One survey found that women
can experience it an average of 4.2 years after completion of treatment.4 A cross-sectional
study investigated sleep-wake disturbance in BCS who were a mean of 5.6 years after
completion of cancer treatment and age-matched them to women without breast cancer.5
Sleep disturbance was found to be more common and more severe in the BCS. Mean
global PSQI scores were significantly different between groups (p<0.01), and the PSQI
sub-categories of sleep quality, sleep latency, sleep duration, number of disturbances, and
daytime dysfunction were all found to be significantly worse (p<0.05 for all variables) in
women with breast cancer.5 A strength of this study was that it included a sample of
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African American BCS, adding to the diversity and generalizability of results.
Limitations include the fact that the percentage of women on endocrine therapy in the
sample was low, so it may not be representative of all BCS. Further, there could be a
source of selection bias as women were recruited to a “quality of life study” and this may
attract women who are already seeking improvement in their sleep disturbance.5
2.2.2 Interventions for Sleep Disturbance in Breast Cancer Survivors
Treatment for sleep disturbance in BCS is primarily focused on the use of either
pharmaceutical interventions or CBT-I. The choice of medication is usually from one of the
following classes: non-benzodiazepine hypnotics, benzodiazepines, or sedative
antidepressants.6 All three classes have shown to be beneficial for sleep in cancer patients;
however, they each contain a side effect profile and the first two classes have habit-forming
and addiction potential, respectively.6 Additional pharmaceutical treatments include
melatonin, some types of antipsychotic medications, anticonvulsants, and valerian root.6
These medications have proven beneficial for sleep disturbance for BCS in the short term,
but they are not meant to be used for chronic insomnia. Additionally, side effects can further
complicate comorbidities. 6
CBT-I is a form of psychotherapy that uses the techniques of stimulus control
behaviors and sleep restriction to help a patient learn how to better sleep.7 It is the goldstandard treatment for insomnia as recommended by the American Academy of Sleep
Medicine.7 It has shown to be effective for insomnia in cancer survivors and, unlike
medications, has effects that last after cessation of treatment.6 Though benefits exist,
successful treatment with CBT-I is often dependent on access to clinicians, insurance
coverage of sessions, and a patient’s willingness to attend sessions.7,8 Often clinicians lack
13

knowledge of effective treatment options for insomnia like CBT-I and there is a shortage of
providers with adequate training in the intervention.8 Yet, sleep disturbance continues to be
a major concern for BCS with many reporting their symptoms going untreated.9 There is a
need to offer more treatment options for sleep disturbance in this population.
After CBT-I, exercise is a primary non-pharmaceutical intervention recommended
for sleep disturbance and multiple studies have demonstrated its benefits.6 A meta-analysis
of 33 RCTs demonstrated that exercise had benefits on mental health, emotional and social
well-being, and depression and anxiety in BCS.10 One study randomized postmenopausal
BCS to either a 3-month exercise intervention or a control group and they found the
intervention group to have significant improvements in PSQI-rated sleep duration
(p=0.03).11 This study had some limitations including small sample size, the inclusion of
only women who had completed primary treatment, and only women with ductal carcinoma
in situ or stage I-II breast cancer.11 In a second study, a 3-month long exercise intervention
based on physical activity recommendations by the American Cancer Society was found to
significantly improve PSQI global sleep quality scores compared to a usual care intervention
(mean between-group difference= -1.4; 95% CI=-2.1 to -0.7; p<0.001) in BCS.12 The results
remained significant at a 6-month follow up as well (mean between-group difference=-1.0;
95% CI=-1.7 to -0.1; p=0.01).12 This study lacked generalizability as underrepresented racial
and ethnic groups represented only a fraction of the study participants. However, a large
sample size, strict randomization, and higher retention rates presented strengths that give the
results more validity.12
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2.2.3 The Benefits of Qigong
The benefits of Qigong extend to multiple aspects of health and well-being. This
association has been studied in both the general population and in cancer patients. For the
purpose of this literature review, we will include some studies that combined Tai Chi
with Qigong or used gentler forms of Tai Chi. A review of the health benefits of Qigong
and Tai Chi in the general population including healthy elderly individuals and those with
chronic disease found benefits on the cardiorespiratory systems, physical function,
balance and falls prevention, bone health, and patient-reported symptoms including
quality of life, mood, and fatigue.13 One study investigated the effects of Qigong exercise
in community-dwelling older adults with a mean age of 74.8 after a twice-weekly Qigong
exercise session for eight weeks.14 Results showed statistically significant improvement
in physical ability (p<0.001), functional health (p=0.001), balance (p<0.001), functional
reach (p<0.001), depression (p=0.005), and spiritual well-being (p=0.004).14 The study
also reported good adherence to the Qigong regimen with approximately 94% of
participants performing Qigong at least once a week outside of sessions.14 Participants
reported that the benefits they received from the practice gave them more incentive to
continue with it. The study further demonstrated the physical benefits of Qigong to be
comparable to that of aerobic exercise as there was a significant mean change in the sixminute walk test (6MWT). It should be noted that there was no control group in this
study which brings forth a possible limitation of extension of these results and
conclusions should be more conservative.14
In addition to Qigong being studied in the general population, it has also been
studied in patients with various forms of cancer. One study compared Medical Qigong to
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a usual care group in patients with breast, lung, prostate, and colorectal cancers.15 The
Medical Qigong group had significant improvement in overall quality of life (p<0.001),
fatigue (p<0.001), mood disturbance (p=0.021), and inflammation as measured by Creactive protein (CRP) (p<0.044).16 It must be noted that this study did not explicitly
define the usual care group making it difficult to interpret and apply the results of this
study. Still, a similar study also reported that Medical Qigong improved inflammation
and cognitive function.17 Finally, a third study on patients with advanced-stage non-small
cell lung cancer and those with gastrointestinal cancer found that Medical Qigong
appeared to have equivalent effects as standard endurance and strength training on
anxiety, depression, and quality of life.18
Three studies have demonstrated the benefits of Qigong, or a combination of
Qigong/Tai Chi, on sleep in patients with cancers other than breast cancer. In patients
with non-Hodgkin’s lymphoma undergoing chemotherapy, there was a statistically
significant improvement in sleep quality over time from pre-test to post-test (p<0.001)
after 21 days of a Qigong intervention.19 When Qigong/Tai Chi was compared to exercise
and a waitlist control in a population of prostate cancer patients during radiation therapy,
sleep duration of participants in the Qigong/Tai Chi group was significantly longer than
that of the exercise group (p=0.047); there was also a trend for longer sleep duration in
the Qigong/ Tai Chi group compared to the waitlist control group (p=0.07).20 However,
the difference was no longer significant at the end of radiotherapy or at follow up time
points. It must be noted that this study was limited by a small sample size.20 Another
study explored sleep disturbance in survivors of nasopharyngeal cancer by comparing a
6-month Qigong/Tai Chi intervention to a control group receiving no therapy.21 Sleep
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disturbance, measured with the Medical Outcomes Study Sleep Scale (MOS), statistically
decreased in the Qigong/Tai Chi group (p<0.006) between mid-intervention and follow
up, indicating that the results were durable.21 A limitation of this study was a lack of
randomization of group allocation, presenting possible selection bias, as well as a high
total attrition rate, though an intention-to-treat analysis was used.21
Qigong has been studied regarding its effect on the health and well-being of
women with breast cancer. One study conducted in Malaysia investigated quality of life
with the FACT-B in BCS participating in either a Qigong exercise group, a standard
exercise program group, or a usual care group.22 The Qigong group’s mean FACT-B
scores at the end of the 8-week intervention period were 7.1 units higher (95% CI=0.3613.9) than the exercise group, and 6.7 units higher (95% CI=0.04-13.3) than the usual
care group.22 Similarly, an RCT conducted in Thailand in 2015 investigated the effects of
a Qigong/Tai Chi program on self-esteem, fatigue, cortisol, and quality of life in women
with breast cancer.23 Participants were assigned to either a 4-week Qigong program or
exercise intervention. Outcome measures included self-esteem as measured by the
Rosenberg Self-Esteem Scale (RSE), fatigue as measured by the Fatigue Symptom
Inventory (FSI), quality of life as measured by the FACT-B, and stress measured with
cortisol samples.23 Mean scores across 12 weeks significantly changed only in the
Qigong group (p<0.05 for all four outcomes) and remained significant after controlling
for baseline scores.23
The generalizability of these studies is limited by the fact that both were
performed in Asian countries and had small sample sizes.22,23 People in Asian countries
are more familiar with the practice of Qigong compared to people living in the United
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States, so prior knowledge of the practice and its benefits could have presented sources of
information bias to participants in these studies.22,23 Nevertheless, findings from these
studies as well as others have demonstrated Qigong to be a safe and beneficial CM
treatment for BCS.22-24
2.2.4 Qigong as an Intervention for Sleep Disturbance in Female Breast Cancer
Survivors
Four studies to date have investigated the use of Qigong as an intervention for
sleep disturbance in BCS. The first was an RCT conducted in Shanghai, China in 2013
looking at the effect of Qigong practice on quality of life outcomes including depressive
symptoms, fatigue, sleep disturbance, overall quality of life, and stress in women with
breast cancer undergoing radiotherapy.25 Women with stage 0-III breast cancer were
randomized to a Qigong intervention or waitlist control. Women in the Qigong
intervention attended five, 40-minute Qigong classes throughout a 5-6-week period and
were given additional materials to encourage practice on their own on non-meeting days.
All participants completed the Center for Epidemiologic Studies Depression Scale (CESD) to assess depression, the Brief Fatigue Inventory (BFI) to assess fatigue, the PSQI to
assess sleep disturbance, and the Functional Assessment of Cancer Therapy- General
(FACT-G) to assess overall quality of life. Stress was measured by salivary cortisol. Data
were collected at baseline (T1), during the middle of radiation therapy (T2), during the
last week of radiation therapy (T3), and 1 month (T4) and 3 months (T5) after the
completion of radiation therapy. To evaluate the effectiveness of the intervention, the
group by time interaction was investigated and they compared least squared means for

18

each group at each time point while controlling for baseline levels of each outcome
variable.25
Multilevel modeling analysis revealed a significant main effect of depression
scores decreasing over time (F (4,367)=10.91, p=0.001) indicating that depression scores
decreased in the Qigong group but not in the waitlist control group.25 There were no
significant group differences for fatigue, sleep disturbance, overall quality of life, or
cortisol rhythms. When baseline symptoms of depression were controlled for, there were
statistically significantly lower depressive symptoms (F (4,368)=3.98; p=0.004), fatigue
(F (3,275)= 4.25; p=0.01), and overall quality of life scores (F (3,275)=3.03; p=0.02) in
the Qigong group versus the waitlist control group.25 Although the results of this study
did not demonstrate the benefits of Qigong on sleep, it was demonstrated that Qigong can
benefit quality of life in women with breast cancer undergoing radiotherapy, and that the
benefits can potentially extend beyond treatment completion. Further, this study
demonstrated Qigong to be a safe therapy for patients in active treatment and adherence
was high, with 65% of participants adhering to at least 80% of the Qigong classes.25
There were limitations to this study that could potentially explain the lack of
effect of the intervention on sleep. First, there was no active control group.25 It cannot be
ruled out that the effects of the intervention were due to social support at classes, a
scheduled routine, or the attention participants gave to the intervention, as opposed to the
waitlist control group that had no guidance or regimen. The sample was limited to
Chinese women in one site in Shanghai, China. Though women with prior practice of
Qigong were excluded from the study, it cannot be ruled out that participants may have
had prior knowledge of Qigong and its benefits with it being of Eastern medicine origin.
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This brings forth a possible source of information bias on the part of the participants.
Furthermore, this limited sample inhibits the generalizability of results to the whole of the
breast cancer population. It is not clear whether all participants in the sample had
completed or were undergoing chemotherapy or endocrine therapy.25 Therefore, it is
possible this sample experienced sleep disturbance to different degrees than a sample
would have that had all undergone some form of chemotherapy. It must be recognized
that breast cancer patients undergoing treatment have been found to be more likely to
experience sleep disturbance than those not undergoing treatment, and treatment effects
can extend beyond the completion of therapy.3,4 Finally, follow up at three months after
completion of radiation therapy may not have been long enough to see the benefits of
Qigong on sleep. Therefore, studies with longer follow up after completion of therapy are
needed.
The second study to look at the association was a double-blinded RCT
investigating the effects of a combined Qigong/Tai Chi Easy (QC/TCE) intervention on
fatigue, depression, and sleep disturbance in BCS.26 Their aim was to test the effect of the
meditative movement component of QC/TCE so the physical activity component was
kept constant by comparing the intervention to a placebo “sham Qigong” (SQG). The
SQG intervention used similar moves as the QC/TCE intervention but removed the
emphasis on breathing and meditation. The interventions were both one-hour-long
sessions meeting twice per week for 12 weeks and participants were blinded and
randomized to the interventions. Eighty-seven postmenopausal women diagnosed with
stages 0-III breast cancer who were 6 months to 5 years past primary treatment including
surgery, radiation, or chemotherapy and reporting clinically significant fatigue were
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enrolled in the study. Outcomes of the study included fatigue as measured by the FSI,
sleep disturbance as measured by the PSQI, and depression as measured by the Beck
Depression Inventory (BDI); outcomes were measured at baseline, post-intervention, and
at 3 months follow up. Hierarchical linear models were used to assess independent effects
of the interventions and time, and a likelihood ratio test was used to assess the interaction
between time and intervention.26
There was a statistically significant decrease in fatigue in the QC/TCE group at
both the post-intervention timepoint (p=0.005) and at the 3-month follow up time point
(p=0.024).26 There was also a statistically significant interaction between the
interventions and time for fatigue (p=0.0116). There was no statistically significant
interaction between the two groups across time for either depression (p=0.94) or sleep
disturbance (p=0.27). However, in both the QC/TCE and SQG groups individually there
were statistically significant decreases across time for both depression and sleep
disturbance (both p<0.05). These results demonstrated that the QC/TCE group was
superior to the SQG group for BCS experiencing fatigue over time. They also
demonstrated that both the QC/TCE intervention and the SQG intervention improved
participants’ depression and sleep disturbance over time, independently.26
A strength of this study is that the “placebo” design helped control for any
differences between groups in terms of attention, focus, or social aspects of being in a
class, which other studies have lacked.26 It allowed the investigators to analyze the
meditative and breathing component of Qigong practice independent of the physical
movement component. There were a few limitations to this study with the first being the
possibility that the intervention and control group were not different enough and thus
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lacked a strong enough comparison to see the benefits of one over the other. Furthermore,
intention-to-treat analysis was not utilized which could have biased results by not
accounting for dropouts. In this study, the QC/TCE intervention was specifically
designed to achieve effects for fatigue which could have altered the results with a lack of
focus on the other two outcomes, depression and sleep disturbance. Despite the lack of
significance of between-group interaction on sleep, it is apparent that low-intensity
physical activity, in general, is beneficial for sleep disturbance as both interventions
incorporated this and demonstrated effects over time.26 There is a need for a comparison
group matched for exertion, dose, and frequency to a Qigong group, but with still enough
contrast to elucidate its benefits.
The third study was a single-arm pilot study investigating the benefits of Qigong
exercise on sleep disturbance, fatigue, and quality of life in BCS.9 Participants included
eight women diagnosed with stages I-III breast cancer and an average of 46.4 months
from completion of primary cancer treatment including surgery, radiation therapy, or
chemotherapy and all with a concern for sleep disturbance or fatigue. The subjects
underwent two Qigong training sessions and then one group session per week for six
weeks. In addition, they were instructed to complete exercises at home twice per day
every day. Participants completed assessments at baseline and after the six-week
intervention including the PSQI for sleep, the Multidimensional Fatigue Inventory (MFI20) for fatigue, and the MOS short-form 36 (SF-36) for quality of life. A multivariate
analysis of variance (MANOVA) was performed to look for differences in means
between the outcomes. A MANOVA was also used to analyze significance in each of the
seven subcategories of the PSQI and the eight subcategories of SF-36.9
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There was a significant improvement in global PSQI scores (p<0.01); the mean
score went from 10.3 (SD 3.6) at baseline to 5.4 (SD 2.3) at the end of the study.9 There
was also a significant improvement in the two PSQI subscales of sleep quality and
daytime dysfunction (p<0.007) with the rest of the subscales demonstrating nonsignificance. There were also significant changes in MFI-20 (p<0.01) and SF-36 (p<0.01)
scores indicating improvements in both fatigue and quality of life in the population by the
end of the intervention. The “role limitations due to physical health” subcategory of the
SF-36 was significant (p<0.006) but all other subcategories were not significant.9
This study demonstrated that Qigong exercise can improve sleep and quality of
life in BCS experiencing sleep difficulties.9 It also found a correlation between sleep
disturbance and fatigue as both improved after the intervention. Limitations of the study
include the fact that the study was a pilot feasibility trial without a control group, the
sample size was small, and study participants were not blinded to the intervention.9 Based
on the limitations across these studies, there remains a need for an active control
comparison group to fully investigate the effectiveness of Qigong.
The final study explored whether Tai Chi Chih (TCC), a slower and more gentle
form of Tai Chi, was noninferior to CBT-I in BCS with diagnosed insomnia.7 Study
participants included ninety female BCS who fulfilled criteria for insomnia in the
Diagnostic and Statistical Manual Fourth Edition (DSM-IV) and the International
Classification of Sleep Disorders, and who reported sleep difficulties greater than or
equal to three times per week for greater than three months, and had completed treatment
at least six months prior to the start of the study. Participants were randomly assigned to
either TCC or CBT-I. The TCC intervention participated in one, 2-hour long group
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session per week for three months that focused on movement meditation with an
emphasis on control over physical function. The CBT-I intervention followed the same
time, frequency, and length as the TCC intervention and was also delivered in a group
format. Both groups participated in assessments at baseline, 2 months, 3 months, 6
months, and 15 months after the start of intervention. One assessment was the PSQI to
measure insomnia treatment response, with the primary outcome being treatment
response at month 15; behavior outcomes were also assessed using the FSI for fatigue,
the Epworth Sleepiness Scale for sleepiness, and the Inventory of Depressive Symptoms
for clinician-rated depressive symptoms. Participants also completed daily diaries using
the Pittsburg Sleep Diary. Method of analysis was noninferiority using an F statistic from
linear mixed models for the primary outcome, and Fisher’s exact test for secondary
outcomes.7
Results demonstrated noninferiority of TCC to CBT-I at the primary outcome
endpoint of month 15 (p=0.02), as well as at month 3 (p=0.02), and month 6 (p<0.01).7
Mean PSQI scores at month 15 were less than the threshold for clinical sleep disturbance
in both groups, demonstrating overall treatment effects (p<0.001). There were nonsignificant between-group differences (p>0.4) in total sleep time and wake after sleep
onset from sleep diary data. For secondary outcomes, there were improvements in both
groups on fatigue severity, daytime sleepiness, and depression (p<0.001), but betweengroup differences in the three categories were non-significant (p>0.5).7
This study demonstrated TCC to be noninferior to CBT-I on BCS with clinical
insomnia.7 The benefits were found to persist after one year of follow up in both groups.
Treatment exposure in the two groups were matched on time, frequency, and length.
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Participants were blinded to the treatment protocol which helped to reduce information
bias. The sample was somewhat limited with the majority of women being white and
well-educated, limiting the generalizability of results. Another limitation to this trial was
low adherence to TCC practice outside of sessions; yet because the two interventions
were exposure matched, this did not appear to affect noninferiority results.7 Although
TCC and Qigong differ, results from this study can be extended to the use of Qigong in
our study as the foundation of both TCC and Qigong is that of meditative movement with
a gentler foundation than that of traditional Tai Chi.
2.3 REVIEW OF RELEVANT METHODOLOGY
The following section is a review of methodology that is relevant to the proposed
study. A more detailed explanation of the proposed study methods is discussed in Chapter
3.
2.3.1 Study Design
The proposed study will be a two-arm, single-blinded RCT examining the benefits
of a biweekly Qigong class compared to a biweekly light exercise class for 12 weeks on
sleep disturbance and quality of life in female BCS. The study will recruit from two
hospitals in the Yale New Haven Health system in New Haven, CT as well as private
oncology practices and support groups. The study will be conducted at community
centers in the New Haven, CT area.
The choice of an RCT as the study design stems from a lack of previously
conducted RCTs comparing Qigong with an active control with the primary outcome of
sleep disturbance in BCS. As discussed previously, only three studies have utilized an
RCT design to investigate Qigong or Qigong/Tai Chi on sleep in breast cancer patients or
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survivors.7,25,26 These studies lacked generalizability with small sample sizes and limited,
non-representative populations. Additionally, one study compared Qigong to a “sham
Qigong” that potentially did not offer enough contrast as a control to the Qigong
intervention itself.26 No previous study directly compared Qigong to dose- and
frequency-matched active exercise. A pilot pre-, post-intervention single-arm study
showed benefits of Qigong on sleep in BCS; however, the single-arm nature of this study
without a comparison group limited validity of results.9 Despite this lack of robust RCTs,
other CM studies have utilized the RCT design including those comparing Qigong to
exercise on patients with prostate cancer and non-Hodgkin lymphoma, as well as a study
comparing Iyengar yoga to regimented exercise in female breast cancer patients.19,20,27
These studies allowed for the elimination of possible bias and confounders within the
sample population by randomizing participants and standardizing a comparison
group.19,20,27 For these reasons our study will follow the same design.
The proposed study will recruit participants from multiple sites to improve upon
the small sample sizes and limited variation in populations of previous studies. We hope
to extend the generalizability of our results and recruit a representative and larger sample
population by recruiting from multiple sites. Recruitment in the proposed study is based
on a study in which participants were recruited via two hospital state tumor registries in
Connecticut with supplementation of referrals from both providers and self-referrals.28
We will also recruit from Sisters’ Journey, a support group for African American women
with breast cancer or a history of breast cancer in New Haven, CT. We hope to increase
the heterogenicity of our sample population and the generalizability of results by
including this site in our recruitment process.
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2.3.2 Selection Criteria
A complete list of inclusion and exclusion criteria can be found in Chapter 3.
Selection criteria are based on previous studies of similar populations.9,26 Participants will
be considered for our study if they are at least 18 years old, have been diagnosed with
stages 0-III breast cancer, are six months to five years past completion of primary
treatment for breast cancer (surgery, radiation, chemotherapy, or endocrine therapy), and
show no evidence of cancer recurrence. Unlike previous studies that have either not
required an insomnia diagnosis or strictly required an insomnia diagnosis for enrollment,
we will enroll participants who score greater than a five on Global Sleep Quality on the
PSQI. This is the threshold between which self-reported good and poor sleepers are
distinguished.29 Assessments will be administered upon enrollment with baseline
assessment data. We will exclude women who have a diagnosis of a concurrent medical
condition likely to influence short-term survival, a history of a major psychiatric illness
requiring hospitalization including severe sleep-wake disorders, and current alcohol or
drug dependence.30 Exclusion of these factors will help preclude the possibility of results
being attributed to other conditions rather than our intervention. The current use of sleep
medication will not be part of the exclusion criteria. There is a sub-score on the PSQI that
accounts for sleep-medication use, and randomization to intervention should account for
any baseline differences between groups.
We will exclude women who have prior experience with Qigong and/or Tai Chi.
This choice is consistent with one study that excluded women who had previous
experience with Qigong or Tai Chi, but only within the past year.25 This was especially
important in the study as these practices are extremely well known in China where the

27

study was conducted. Another referenced study excluded those who had practiced
Qigong or Tai Chi within the past year, as well as patients with physical disabilities
including an inability to walk unassisted, chronic pain while walking, or difficulty
walking for 20 mins.20 We will follow suit regarding physical ability as both of our
treatment groups require baseline abilities in order to perform the movements.
2.3.3 Potential Confounding Variables
Confounding variables can threaten the validity of the results of a study. Like
previous studies, variables to be considered in this study include age, race, comorbidities,
cancer stage, cancer treatment, treatment with endocrine therapy, time since diagnosis,
menopausal state, baseline sleep quality, body mass index (BMI), and baseline level of
physical activity.12,26 These are consistent with previous studies that have looked at
Qigong or exercise on sleep in BCS.12,26 We will explore some of these variables in this
review.
Studies are mixed regarding what age range experiences the most sleep
disturbance in BCS. One reported that younger women may have a worse disease burden
than their elder counterparts considering they will more likely be dealing with concurrent
career and childcare concerns.4 They also reported an association between younger age
and both increased disease severity and increased sleep disturbance.4 However, other
studies have demonstrated that sleep disturbance may be worse for women who are postmenopausal and of older age.31 Age is also associated with different physical abilities.32
For these reasons, age will be controlled for in our study. We will include all women
greater than age 18 in our study who meet the other inclusion criteria, and we will control
for age differences with randomization to intervention.
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Menopausal state, whether pre- or post-menopausal, endocrine symptoms, and
treatment with endocrine therapy can all affect sleep disturbance in BCS.33 Sleep
disturbance is common in menopausal women independent of whether they are a BCS or
a healthy woman.33 Treatment with endocrine therapy can affect sleep disturbance as well
as physical ability.34 Aromatase inhibitors (AI), a type of endocrine therapy, have been
associated with both insomnia and arthralgias.34 In this study we will control for baseline
menopausal symptoms by administering the Functional Assessment of Cancer TherapyEndocrine Symptoms (FACT-ES) at baseline to control for differences between groups.
To control for differences in menopausal status and treatment with endocrine therapy we
will use self-report at enrollment.
Body mass index (BMI) and baseline physical activity are other possible
confounders to be considered in our study. High BMI and obesity are prevalent in BCS
and predictive of worse overall survival than normal BMI.31,35 Additionally, obesity is
associated with sleep conditions such as sleep apnea and increased daytime sleepiness.31
Breast cancer treatment has been found to cause decreased physical activity both during
and after treatment which can further contribute to sleep difficulties.5 Again,
randomization of our sample to each intervention will attempt to control for differences
in our population in regards to these factors. We will administer the International
Physical Activity Questionnaire (IPAQ) at baseline to further account for any differences
between groups.
2.3.4 Randomization and Blinding Technique
Randomization of participants to intervention will be based on two studies that
investigated CM interventions on sleep in cancer survivors.7,36 Both of these RCTs used a
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computerized random number generator and a 1:1 allocation to the intervention and
control groups. Randomization in this way allowed for baseline characteristics to be
controlled for and reduced the possibility of bias from confounding variables. The
proposed study will follow the same guidelines for the allocation process.
Blinding of the proposed study will follow suit with a study that used a partial
blinding protocol in which participants were blind to the hypothesis as well as the content
of the other treatment group.7 Due to the nature of the intervention, participants cannot be
blinded to their specific interventions. However, this method of partial blinding should
allow for reduced information bias. In accordance with the same study, investigators and
outcome assessors will be blinded to subject allocation at baseline and at assessment
points thus creating a single-blinded trial.7
2.3.5 Intervention
The Qigong intervention will follow the framework used by three studies.14,20,37
The outcomes for our study will be based on the Layers Model created by Yang et al.,
and the framework of our intervention will follow this study in combination with another
study that also based their intervention on the Layers Model.14,37 The first study created a
Qigong exercise regimen comprised of seven movements; a sequence that was short and
easy to remember but incorporated a wide range of motion for the entire body.37 Their
study centered on the need for the intervention to be accessible to nearly any level of
physical ability and experience.37 The second study employed a “Health Qigong”
program based on gentle bodily movements, breathing exercises, and meditation taught
and led by a Qigong practitioner and conducted in groups of 10-15 people to traditional
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music.14 Unlike the first study whose intervention was three times per week for 24 weeks,
we will follow suit with a third study in implementing a 12-week-long, biweekly
intervention.20 This will attempt to ensure participant adherence to the intervention and to
avoid loss to follow up.
Instructors for the intervention will be trained under the accreditation standard
guidelines for Tai Chi and Qigong by the Medical Tai Chi and Qigong Association
(MTQA).38 The guidelines were developed by health professionals, integrative medicine
academics, Tai Chi and Qigong master instructors, and public safety officers from
countries including USA, China, Canada, Korea, and several countries in Europe.38
The light exercise comparison group will be based on the light exercise program
that a referenced study implemented who compared Qigong to light exercise on sleep in
survivors of prostate cancer.20 Their light exercise program was led by an exercise
physiologist and consisted of light resistance training and stretching, with the level of
exertion and movement matching that of their Qigong intervention. As these researchers
did, we will implement an active control in our study with light exercise matched on
dose, frequency, and length to our Qigong intervention.
2.3.6 Primary and Secondary Outcome Measures
The Layers model is to be used as the basis for the outcomes in our study. It was
developed by Yang et al. when they investigated the subjective experiences of
Qigong/Tai Chi in older adults after a six-month intervention using semi-structured
interviews.37 The model is based on the idea that Qigong/Tai Chi affects participants in
five overlapping dimensions: physical, mental, emotional, social, and spiritual. As

31

participants go deeper and longer into their practice, they transition from experiencing
benefits in a single dimension (Layer 1) to experiencing complex integration of four
and/or five dimensions (Layer 4).37 Limitations of the study include small sample size, a
purposeful selection process, and subjective data as results, bringing about considerations
for both selection bias and information bias.37 Still, the Layers Models presents a strong
foundation to investigate our outcomes in this study. On this basis, our outcomes will be
sleep disturbance as measured by the PSQI, objective sleep parameters as measured by a
Fitbit Alta HR, and quality of life in the four other dimensions as measured by the FACTB and the FACIT-sp.
The primary outcome of this study is subjective sleep disturbance as measured by
the PSQI. The PSQI is a 19-item self-report questionnaire that assesses sleep quality and
quantity.29 The Global Sleep Quality scale is an overall sleep quality score that uses the
19 items to assess global sleep quality with higher scores indicating worse sleep quality.29
It has a reliability coefficient, or Cronbach’s alpha, of 0.83 in the general population.29
There is evidence supporting the internal consistency of the PSQI in cancer patients. Data
from two studies on the Global Sleep Quality scale from the PSQI in cancer patients
yielded Cronbach’s alphas of 0.81 and 0.77, demonstrating this tool as reliable in the
assessment of sleep in cancer patients.29 A score of greater than 5 on Global Sleep
Quality distinguishes between good and poor sleepers and has a diagnostic sensitivity of
89.6% and specificity of 86.5%.29 The questionnaire also yields 7 component subscales:
subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep
disturbances, use of sleep medication, and daytime dysfunction.29
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One secondary outcome will be objective measures of sleep patterns recorded by
a Fitbit Alta HR. Adding an objective measure of sleep will help reduce sources of
response bias from the self-report PSQI. Polysomnography (PSG) is the gold standard
objective measurement for the diagnosis of sleep disorders but there remain a few
disadvantages.39 The environment in which it is conducted can be uncomfortable,
anxiety-provoking, and can interfere with sleep.39 It is also expensive, requires trained
technicians, and formal sleep facilities, yet less than 50% of sleep studies in recent years
have been conducted in formal sleep facilities.39 Wristband actigraphy is another
objective measure of sleep widely used in sleep studies that senses accelerated motion.39
However, this technology is also expensive with watches and software ranging from
$1225 to $1850 a piece.40 It has been found to overestimate sleep time and has a low
sensitivity for detecting wake after sleep onset time (WASO).39 Instead, this study will
measure objective sleep patterns using the Fitbit Alta HR, a wearable wrist device that
can measure both daytime activity and sleep.39 It is easy to use, already widely used by
many consumers, and inexpensive at about $100 per device.40
The Fitbit Alta HR uses body movement, heart rate, and heart rate variability
(HRV) to assess multiple parameters of sleep.39 In this study, the primary outcomes to be
observed by use of the Fitbit will be total sleep time (TST) measured in minutes, sleep
efficiency (SE) measured as a percentage, wake after sleep onset (WASO) measured in
minutes, and sleep onset latency (SOL) measured in minutes; these outcomes correlate
most with the subscales of the PSQI. The Fitbit Alta HR is a newer-generation Fitbit
model and in a systemic review was found to better estimate TST, SE, and WASO than
early-generation models.39 In comparison to PSG, there was a lack of statistically
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significant difference in values of WASO (p=0.92), TST (p=0.29), and SE (p=0.19), as
well as only small differences in SOL (0.03).39 The Fitbit Alta HR was also found to have
higher sensitivity (0.95-0.96) and specificity (0.58-0.69) in detecting sleep epochs than
earlier-model Fitbits and actigraphy.39
Other secondary outcomes in this study will be the four other dimensions of
quality of life affected by Qigong: mental, emotional, social, and spiritual. We will assess
these using the FACT-B and the FACIT-Sp. The FACT-B is a 44-item self-rated
questionnaire that is composed of the FACT-G plus a 9-item subscale specific to quality
of life in those with breast cancer.41 The FACT-G component of the FACT-B is a
multidimensional tool with five subscales including Physical Well-Being (PWB),
Emotional Well-Being (EWB), Social Well-Being (SWB), Functional Well-Being
(FWB), and Relationship with Doctor (RWD).41 The reliability coefficient for the FACTG subscales are noted to be >0.80, but only around 0.63 for the breast cancer subscale,
the FACT-B.41 However, it has been noted that the breast cancer subscale has expected
correlations with other measures of quality of life in this population and may be low due
to items being specific to breast cancer patients.41 The FACIT-Sp is a 12-item subscale of
the FACT-G and is used to assess spirituality specifically for those with chronic and/or
life-threatening illnesses.42 It has a Cronbach’s alpha reliability coefficient 0.87.42
2.3.7 Sample Size and Statistical Significance
Previous data from studies using both Qigong and exercise and the PSQI will be
used to calculate sample size for this study. One study found a mean change of 1.3
points (SD 3.2) on the PSQI at 3 months after an aerobic and strength-based
intervention in BCS, an intervention close to that of the comparison group in our
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proposed study.11 Two other studies found similar mean changes at 1.4 units and 1.49
units; however, one study had a more frequent and vigorous exercise regimen than our
proposed study, and the other was in endometrial cancer survivors, respectively. 12,43 For
these reasons, 1.3 was chosen as this study’s expected mean change for the comparison
group. A study found a mean change of 4.9 (SD 3.6) difference in the PSQI after a 12week Qigong intervention and this study most closely follows the same length,
intervention type, and study population as our proposed study.44 Taking these studies
into account we aim to detect an effect size of 3.6 units on the PSQI with a standard
deviation of 3.6. Analysis of previous clinical trials using Qigong has demonstrated
dropout rates between 2-10%; we will conservatively use 10% as an estimate of
dropout rate in our study. 25,26 Statistical analysis will follow that of a study that used a
multiple time by interaction model.26 Considering multiple comparisons, an alpha of
0.01 with a Bonferroni adjustment for multiple comparisons between groups will be
used with 90% power. Accounting for a 10% dropout rate, a sample size of 36
participants per group, or 72 participants total will need to be recruited for the proposed
study (Appendix C).
2.4 CONCLUSION
This literature review presents studies demonstrating the problem of sleep
disturbance in BCS and its impact on quality of life. There is evidence supporting
different avenues for both pharmacological and non-pharmacological treatment, though
the literature reports that women are seeking more forms of CM treatment for their sleep
disturbance. Qigong is one CM option that has been tested as a means for treating sleep
disturbance in BCS and has demonstrated improvements, yet few robust studies exist
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demonstrating its efficacy. Studies have lacked generalizability with small sample sizes
and restricted sample population characteristics. They have also lacked active controls
with an exercise comparison matched for dose, frequency, and duration of treatment. We
propose a single-blinded RCT comparing the effects of Medical Qigong to light exercise
on sleep disturbance in female BCS who are within six months to five years past
completion of primary treatment for breast cancer. Adding to the literature of this
treatment modality will inform patients on effective means of quality of life improvement
and increase the knowledge base of medical providers when counseling patients.
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CHAPTER 3: STUDY METHODOLOGY
3.1 STUDY DESIGN
The study design will be a two-arm, single-blinded RCT.
3.2 STUDY POPULATION AND SAMPLING
Participants will be sampled on a non-random, consecutive basis via convenience
sampling from multiple sites including the Tumor Registry from Yale New Haven
Hospital York Street Campus and Yale New Haven Hospital Saint Raphael Campus in
New Haven, Connecticut. Participants will also be recruited from Sisters’ Journey
support group, breast and survivorship clinics, and private oncology practices, all in New
Haven, CT, if meeting the study criteria.
See Table 1 for a complete list of inclusion and exclusion criteria. At baseline,
participants will complete the PSQI and only those scoring above a 5 on Global Sleep
Quality, indicating the presence of sleep disturbance, will be included in the study.
Subjects will also complete the FACT-B, the FACIT-Sp, the FACT-ES, and the IPAQ at
baseline. There will be a baseline characteristics enrollment survey completed upon
enrollment.
Table 1. Inclusion and Exclusion Criteria
Inclusion Criteria

Exclusion Criteria

Female age ≥ 18 years old

Diagnosis of a concurrent medical
condition likely to influence short-term
survival

Clinical diagnosis of breast cancer stages
0-III
6 months to 5 years past completion of
primary cancer treatment (surgery,

History of a major psychiatric illness
requiring hospitalization including severe
sleep-wake disorders
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radiation, chemotherapy, or endocrine
therapy)
No evidence of cancer recurrence
Ability to read and write in English
Physically capable of participating in
exercise

Current alcohol or drug dependence
Practice of Qigong or Tai Chi within the
last year
Physical disabilities including an inability
to walk unassisted, chronic pain while
walking, or difficulty walking for 20 mins

A score of >5 in Global Sleep Quality on
the PSQI

3.3 SUBJECT PROTECTION AND CONFIDENTIALITY
The clinical site will be IRB approved under the Yale Human Investigations
Committee (HIC). All research staff will undergo Health Insurance Portability and
Accessibility Act (HIPAA) training before the start of the study. Any protected health
information (PHI) will only be accessed by HIPAA-trained research staff and only
accessed through university-approved secure electronic health records (EHR) on
encrypted devices. A partial waiver of authorization under HIPAA will be requested to
access the Tumor Registry PHI. Each participant will be provided with the details of the
study as well as risks, benefits, and statements of confidentiality. They will be given an
opportunity to read and ask questions regarding the most updated IRB approved
Authorization and Consent form (Appendix A), and will be asked to give written, signed
consent.
3.4 RECRUITMENT
The primary recruitment process will include the use of the hospital Tumor
Registry from Yale New Haven Hospital York Street Campus and Yale New Haven
Hospital Saint Raphael Campus which will generate a list of eligible subjects. We will
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use passive physician consent for this recruitment strategy. The provider of each subject
will be contacted via a letter from the primary investigator. The provider will be asked to
identify any patients who should not be approached for the study. If providers do not
identify patients not to contact within two weeks, the research staff will contact subjects
from the Tumor Registry list to determine interest in participation. Additional recruitment
will involve the distribution of flyers to the Sister’s Journey support group, breast and
survivorship clinics, and Yale Cancer Center Community Care practices.
Interested participants will be evaluated by research staff for eligibility. Research
staff will provide information about the study including risks and benefits and schedule
an appointment for informed consent and baseline assessments. Recruitment and
enrollment into the study will take place over nine months on an ongoing basis.
3.5 STUDY VARIABLES AND MEASURES
Qigong Intervention: The Qigong intervention will consist of two, 60-minute group
sessions per week for 12 weeks. Participants will be encouraged to practice at home
outside of sessions using materials provided. Groups will consist of 12 people and will
take place at various community centers in New Haven, CT led by accredited Qigong
instructors. The intervention will be based on seven movements: “Preparatory Form”,
“Lazy About Tying Coat”, “Fist Under Elbow”, “Step Back and Whirl Arms on Both
Sides”, “Part Horse’s Mane”, “Wave Hands Through Clouds”, and “Close”.1 Sample
Qigong movements can be viewed in Figure 1. The length of meditations during class
will increase throughout the 12 weeks to build experience with the practice and attempt to
reap the most benefits. Each session will include a 5-minute warm up, 40 minutes of

42

Qigong exercise, and 5 minutes of relaxation at the end. A 10-minute break will be
provided mid-way through the 40-minute exercise session.
Figure 1. Sample Qigong Movements

Chang PS, Knobf MT, Oh B, Funk M. Physical and psychological effects of Qigong exercise in
community-dwelling older adults: An exploratory study. Geriatr Nurs. 2018;39(1):88-94.

Active Control: The light exercise program will consist of group exercise classes
matched for the time of the Qigong intervention: two, 60-minute sessions per week for 12
weeks. Participants will be given materials and encouraged to practice their exercises at
home on off days. The program will be implemented in groups of 12 and will be led by a
trained exercise physiologist. Exercises will focus on light resistance training and
stretching with a mild aerobic component matching the level of exertion and movement
expected in the Qigong group. Stretching exercises will align with the targeted muscle
groups of that day’s training. The light exercise group will also be conducted at
community centers in New Haven, CT, but at different locations than the Qigong group
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as to not allow the two groups to have a chance of seeing the other intervention. The
active control will have the opportunity to enroll in Qigong classes equivalent to our
intervention at the conclusion of the study free of charge.
Adherence to Assigned Intervention: Adherence to the interventions will be
ensured using documented attendance at each session as well as at assessment points.
Instructors at each session will pass around an attendance sheet. Additionally, research
staff will conduct random observations of sessions of each group to ensure intervention
fidelity. Participants in both groups will be asked to log hours of exercise outside of
group classes. Participants will be encouraged to discontinue their usual exercise routine
during the study.
Primary and Secondary Outcomes: The primary outcome measure for this study is
sleep disturbance as measured by the PSQI (Appendix B). A Fitbit Alta HR will measure
objective sleep parameters including total sleep time (TST, min), sleep efficiency (SE,
%), wake after sleep onset (WASO, min), and sleep onset latency (SOL, min). These
objective outcomes will be considered secondary outcome measures. Fitbits will be given
to participants at the onset of study free of charge and participants will wear them
overnight the night before each assessment point. Other secondary outcomes include
quality of life in the five remaining dimensions as presented in the Layers Model of
Qigong—mental, emotional, social, and spiritual—and will be measured using the FACTB and the FACIT-Sp.
Baseline Variables: At baseline participants will complete an enrollment survey
which will ask patients about age, cancer stage at diagnosis, time since treatment, type of
treatment, treatment with endocrine therapy, education level, income, menopausal status,
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BMI, and insurance coverage. Baseline characteristics will also be gathered through the
EHR if a participant is unsure of an answer. Participants will complete the PSQI, FACTB, and FACIT-Sp at baseline; they will also complete the FACT-ES and the IPAQ to
assess baseline endocrine symptoms and physical activity, respectively.
3.6 BLINDING OF INTERVENTION AND OUTCOME
Blinding of intervention: Due to the nature of the intervention it is not possible to
blind participants or instructors to both groups. However, participants will be blinded to
the hypothesis as well as to the alternative group for the duration of the study. Instructors
will also be blinded to the hypothesis and will only be informed that the study is for
improvement in lifestyle for BCS. Participants will be instructed not to discuss their
intervention when undergoing assessments.
Blinding of Outcome: The study will follow a single-blinded approach where
investigators and outcome assessors will be blinded to allocation at baseline and each
assessment point.
3.7 ASSIGNMENT OF INTERVENTION
Upon enrollment, participants will complete baseline assessments and then be
randomized to intervention. A computerized random number generator will randomize
patients with 1:1 allocation to intervention or control. Investigators and other staff will be
blind to allocation as each allocation will be concealed in a sequentially numbered,
opaque, and sealed envelope. They will also not have access to participant data before
allocation.
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3.8 DATA COLLECTION
Subjects will complete the IPAQ and FACT-ES at baseline and all remaining
questionnaires at baseline, at the end of the 12-week intervention, and again at 3 months
and 6 months follow up. The 6-month follow up timepoint will allow researchers to
assess the lasting effects of the Qigong intervention in our population. Participants will
retrieve Fitbits at enrollment and wear them overnight at home the night before each
assessment point. The next day upon questionnaire assessment participants will return
Fitbits to research staff for data collection and receive them back before leaving.
Research staff will be trained on each questionnaire and on Fitbit software, and will score
each tool at every time point.
3.9 SAMPLE SIZE CALCULATION
A simple t-test calculator Power and Precision version 4.0 (Biostat Inc.) was used to
look for a difference in means for an anticipated effect size of 3.6 units on the PSQI with
a standard deviation of 3.6, though the actual test will be a fixed-effects model. A sample
size of 32 participants per arm is needed to provide 90% power. To account for multiple
comparisons, we are adjusting the alpha to 0.01 with a Bonferroni adjustment for
multiple comparisons between groups and the effects of time interaction. The final
sample size will account for an estimated 10% dropout rate and thus a total of 36
participants will be randomized to each arm for a total of 72 participants in the study
(Appendix C).
3.10 ANALYSIS
Descriptive statistics of baseline characteristics will be run. Continuous variables
including age and time since cancer treatment completion will be reported as means and
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standard deviations. A student t-test will be used to compare continuous variables at
baseline. Relative frequencies will be used for categorical variables including income,
race, insurance status, employment status, education level, cancer treatment type,
menopausal state, and other chronic health conditions including diabetes, hypertension,
hypo- or hyperthyroidism, and any autoimmune disorders. Comparisons between
categorical variables will be conducted using a chi-square test.
Outcome data will be analyzed using an intention-to-treat analysis. Baseline
scores on the PSQI, FACT-B, FACIT-Sp, IPAQ, and FACT-ES will be compared
between groups using a student t-test. Baseline data from the initial night sleeping with
the Fitbit (i.e. TST, WASO, SOL all measured in minutes, and SE measured as a
percentage) will also be compared between groups with a student t-test. The primary
outcome of this study, mean change in sleep disturbance as measure by the PSQI, will be
operationalized as a continuous variable. To determine the statistical significance of the
effect of Qigong versus light exercise, we will use hierarchical linear mixed-effects
models to assess the independent effects of the intervention group (either Qigong or light
exercise) and time (baseline, post-intervention, 3-month follow up, and 6-month follow
up) for the primary and secondary outcomes. The baseline measurement for each
outcome variable will be the reference value for time, with fixed effects for postintervention, 3-month follow up, and 6-month follow up. There will be three, time by
intervention interaction terms since there will be three fixed effects for time (postintervention, 3-month follow-up, a 6-month follow up).
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3.11 TIMELINE AND RESOURCES
The timeline of the proposed study can be found in Figure 2. The proposed study
will take place within two years. Training of research staff and coordination with
intervention sites will take place over the first 3 months. Recruitment of participants for
the study will take place over the next 9 months. The intervention will be 3 months.
Follow up assessments will occur at the end of the intervention, at 3 months, and at 6
months after completion of the intervention. Data analysis and manuscript preparation
will take place within 6 months of study completion.
The principal investigator (PI) for the study will be M. Tish Knobf, PhD, RN,
FAAN and the co-principal investigator (co-PI) will be Elisabeth Mirenda, PA-SII.
Research assistants and statisticians at Yale University will be recruited to help conduct
the study and will be trained in the scoring of each assessment tool, as well as in the use
and scoring of Fitbit software. Qigong instructors and exercise physiologists will be
recruited from the region and compensated for their time. Before the start of the study
and within the first 3 months, the PI and co-PI will approach community centers within
the New Haven, CT area to request the use of facilities for the study. Participants will be
provided with a Fitbit device at enrollment and will be asked to wear the device overnight
the night before each assessment. Participants will be compensated with a $20 Visa gift
card at every assessment point and free parking at study sites. Participants will be given
the opportunity to keep the Fitbit device at the end of the study if desired.
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Figure 2. Timeline of Intervention
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CHAPTER 4: CONCLUSION
4.1 ADVANTAGES AND DISADVANTAGES
This study will be the first to use an RCT design to compare the practice of
Qigong to light exercise with a focus on improving sleep in BCS. Unlike previous studies
that have lacked an active control group, our study will potentially gain insight into the
unique properties of the practice of Qigong and its multidimensional effects by directly
comparing it to an active exercise control.1,2 Through a randomized controlled design, we
hope to gain insight into the benefits of Qigong by minimizing selection bias and
potential bias from confounding variables. Unlike previously discussed studies that have
been limited in sample size and single sites, we hope to extend the generalizability of our
results by gaining a larger sample size and conducting the study at more than one
research site.1,2 By recruiting patients from the Sisters’ Journey support group we will
create a more heterogeneous sample in order to further improve the generalizability of
results. Finally, providing both a subjective and objective measure of sleep will allow
researchers to gain a better understanding with more robust evidence as to the efficacy of
our intervention on sleep.
There are some limitations to the proposed study that must be considered. First,
the single-blinded design presents the possibility for participants to be biased in regards
to their intervention placement. By blinding participants to the hypothesis and to the
comparison group we will attempt to minimize adverse effects on results. There is a
possibility that the length of the intervention of 12 weeks may not be long enough to
provide lasting effects from the Qigong intervention and future studies may consider
providing a longer outcome. However, this study is designed to prevent drop out and the
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length of 12 weeks should help control for it. Our study recommends that women
discontinue their normal exercise routine upon enrollment, yet it is not possible to
completely limit women from partaking in other exercises outside of their assigned
intervention. We will attempt to control for this potential limitation by running the IPAQ
questionnaire on baseline physical activity.
By using a subjective measure of sleep quality in our population, there is an
opportunity for participants to influence their responses by overestimating or
underestimating aspects of their sleep habits. We will attempt to control for this form of
response bias by initiating a concurrent objective measure of sleep with the Fitbit device.
It must be noted that previous studies have demonstrated inconsistencies between
subjective and objective measures of sleep.3 However, none of these studies utilized the
Fitbit device as an objective measure and rather involved either PSG or actigraphy. In
this study the Fitbit will only be worn at assessment points (four times throughout the
study) for one night at a time, whereas the PSQI will ask for information regarding at
least the previous 30 days of sleep. This could potentially provide inconsistencies
between these two measures. The Fitbit has not been widely studied as an objective
measure of sleep, especially in cancer populations as it is still a new device used for
sleep. However, this study poses an opportunity to increase knowledge and data
regarding the device and sleep. Finally, the Fitbit device is a user-dependent device; there
will be those who are familiar and those who are unfamiliar with the device. The device
also may not be user-friendly to older women who are less familiar with the technology.
As with any study utilizing technology, these limitations must be considered when
analyzing results.
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4.2 CLINICAL AND PUBLIC HEALTH SIGNIFICANCE
Breast cancer diagnosis and treatment can adversely affect women’s physical,
psychological, emotional, social, and spiritual well-being and can last for years after
diagnosis. With improved survival, providers will be treating increasingly more women
with post-treatment side effects and comorbidities that affect quality of life, and women
will be seeking treatment options for them. It is important that providers are equipped
with evidence-based guidelines for symptom management. Insurance companies may be
more inclined to pay for alternative treatment modalities when the literature is more
robust regarding their efficacy. If the findings of this study improve sleep and quality of
life in BCS, providers will have evidence for an alternative sleep and healthy lifestyle
behavior to recommend. Qigong is accessible and easy to learn for all ages and abilities.
Previous studies have compared Qigong to CBT-I and future studies should consider
comparing Qigong to medical treatments and how it could be beneficial to implement
lifestyle modalities before medicine.
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APPENDICES
APPENDIX A: AUTHORIZATION AND CONSENT FORM
COMPOUND AUTHORIZATION AND CONSENT FOR PARTICIPATION IN A
RESEARCH PROJECT
YALE UNIVERSITY SCHOOL OF MEDICINE
YALE NEW HAVEN HOSPITAL

Study Title: Medical Qigong Versus Exercise on Sleep Disturbance and Quality of Life
in Breast Cancer Survivors
Principal Investigator: M. Tish Knobf, PhD, RN, FAAN
Co-Investigator: Elisabeth Mirenda, PA-SII
Funding Source: Yale University School of Medicine Physician Associate Program
Invitation to Participate and Description of Project
You are invited to participate in a research study investigating sleep and other aspects of
quality of life in breast cancer survivors using two different types of exercise-based
interventions. You have been asked to participate because you have a history of a
diagnosis of breast cancer and began treatment within the last year. Approximately 72
women with breast cancer will participate in this study.
In order to decide whether or not you wish to be a part of this research study you should
know enough about its risks and benefits to make an informed decision. This consent
form gives you detailed information about the research study, which a member of the
research team will discuss with you. This discussion should go over all aspects of the
research: its purpose, the procedures that will be performed, any risks of the procedures,
possible benefits, and possible alternative treatments. Once you understand the study, you
will be asked if you wish to participate; if so, you will be asked to sign this form.
Description of Procedures
If you agree to participate in this study, you will be randomly assigned to one of two
types of exercise classes in groups of 10-15 people. Random assignment is like flipping a
coin with a 50/50 chance of one group or the other. You will be asked to attend an hour
class twice per week for 12 weeks. You will also be encouraged to work on what you
have learned in class at home on your days off. These classes will take place at
community centers in the New Haven, CT area. Parking will be free of charge. You will
be asked to log your exercise time outside of class. You will receive reminder calls or
texts for sessions from a research assistant. Randomization will be done by a computer
program and will not be based on any personal baseline information. During the course of
the study you will be encouraged to discontinue your current exercise regimen.
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At the start of the study, you will complete 5 questionnaires regarding your sleep habits
and other aspects of your physical, emotional, and psychological well-being. You will
also complete these questionnaires at the end of the 12-week exercise course, and at visits
3 and 6 months after the end of the course. You will be compensated for attendance to
assessment visits in the form of a $20 Visa gift card at each assessment point.
You will be asked to wear a Fitbit wristband device overnight on 4 different nights
throughout the study. Fitbits will be worn the night before your assessment visit at the
start of the study, after the 12-week intervention, and at the 3- and 6-month visits. They
will be returned to research staff at your assessment visit. Information taken from Fitbits
will include heart rate, respiratory rate, and sleep time. You will be allowed to keep the
Fitbit at the end of the study if you desire.
You will be told of any significant new findings that are developed during the course of
your participation in this study that may affect your willingness to continue to participate.
Research results will not be returned to your doctor. If research results are published,
your name and other personal information will not be given.
Risks and Inconveniences
We do not anticipate any major risks in participating in this study. Due to our
intervention being based on basic exercise principles and a decrease in physical activity
among women after breast cancer therapy, there is a potential risk for some side effects
such as muscle aches or strained muscles. Though risks of negative outcomes are small,
our interventions may make participants more aware of psychosocial factors in their lives
and emotional distress. We can provide referrals to appropriate providers if needed.
There is a risk of breach of confidentiality about your health status and participation in
this study, though this is unlikely to occur. All research staff will be thoroughly trained
and certified in the privacy of research studies.
Benefits
Benefits of participation in this study may include improvements in mental, emotional,
social, and spiritual health, improvements in sleep, and improvements in physical health.
This study may also provide information on how to integrate complementary therapy,
such as non-strenuous exercise, into daily lives.
Economic Consideration
Exercise classes will be provided free of charge. Parking at facilities will be free. You
will be compensated at each assessment visit in the form of a $20 Visa gift card. Upon
completion of the study you will be gifted the Fitbit device if you desire to keep it.
Treatment Alternatives/ Alternatives
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The alternative to participating in this study is to decline participation. If you do not wish
to participate you will be provided the standard treatment for sleep-related issues at the
discretion of your healthcare provider.
Confidentiality and Privacy
Any identifiable information that is obtained in connection with this study will remain
confidential and will be disclosed only with your permission or as permitted by U.S. or
state law. Examples of information that we are legally required to disclose include abuse
of a child or elderly person, or certain reportable diseases. Information will be kept
confidential by using only identification numbers on study forms, storing signed forms in
locked cabinets, and password protecting data stored on a computer. When the results of
the research are published or discussed in conferences, no information will be included
that would reveal your identity unless your specific permission for this activity is
obtained.
We understand that information about your health is personal, and we are committed to
protecting the privacy of the information. If you decide to be in this study, the researcher
will get information that identifies your personal health information. This may include
information that might directly identify you, such as your name, birth date, or address.
This information will be de-identified at the earliest reasonable time after we receive it,
meaning we will replace your identifying information with a code that does not directly
identify you. The principal investigator will keep a link that identifies you and your
coded information, and this link will be kept secure and available only to the principal
investigator or selected members of the research team. Any information that can identify
you will remain confidential. The link to your personal information will be kept for 5
years, after which time the link will be destroyed and the data will become anonymous.
The data will be kept in this anonymous form indefinitely.
The information about your health that will be collected in this study includes:
•
•
•

Research study records
Records about phone calls made as part of this research
Records about your study visits

Information about you and your health which might identify you may be used by or given
to:
Representatives from Yale University, the Yale Human Research Protection Program,
and the Yale Human Investigation Committee (the committee that reviews, approves, and
monitors research on human subjects), who are responsible for ensuring research
compliance. These individuals are required to keep all information confidential.
By signing this form, you authorize the use and /or disclosure of the information
described above for this research study. The purpose of the uses and disclosures you are
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authorizing is to ensure that the information relating to this research is available to all
parties who may need it for research purposes.
All health care providers subject to HIPAA (Health Insurance Portability and
Accountability Act) are required to protect the privacy of your information. The research
staff at the Yale School of Medicine and those hospitals involved in this study are
required to comply with HIPAA and to ensure the confidentiality of your information.
You have the right to review and copy your health information in your medical record in
accordance with institutional medical records policies. This authorization to use and
disclose your health information collected during your participation in this study will
never expire.
Voluntary Participation and Withdrawal
Participation in this study is voluntary. You are free to choose not to take part in this
study. Refusing to participate will involve no penalty or loss of benefits to which you are
otherwise entitled (such as your health care outside the study, the payment for your health
care, and your health care benefits). However, you will not be able to enroll in this
research study and will not receive study procedures as a study participant if you do not
allow use of your information as part of this study.
Withdrawing from the Study
If you do become a subject of this study, you are free to stop and withdraw at any time
during its course.
To withdraw from the study, you can call a member of the research team at any time and
tell them that you no longer wish to participate. This will cancel any future appointments.
Withdrawing from the study will involve no penalty or loss of benefits to which you are
otherwise entitled. You may withdraw or take away your permission to use and disclose
your health information at any time. If you withdraw your permission, you will not be
able to stay in this study. When you withdraw your permission, no new health
information identifying you will be gathered after that date. Information that has already
been gathered may still be used and given to others until the end of the research study, as
necessary, to ensure the integrity of the study and/or study oversight.
You do not give up any of your legal rights by signing this form.
Questions
We have used some technical terms in this form. Please feel free to ask about anything
you do not understand and to consider this research and the consent form carefully—as
long as you feel is necessary—before you make a decision,
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Authorization and Permission:
I have read (or someone has read to me) this form and have decided to participate in the
project described above. Its general purpose, the particulars of my involvement, and
possible hazards and inconveniences have been explained to my satisfaction. My
signature also indicates that I have received a copy of this consent form.
By signing this form, I give permission to the researchers to use [and give out]
information about me for the purpose described in this form. By refusing to give
permission, I understand that I will not be able to be in this research study.

Name of Subject: ______________________________________
Signature: ____________________________________________
Date: __________

_______________________________________
Signature of Principal Investigator

_______________
Date

Or

_______________________________________
Signature of Person Obtaining Consent

________________
Date

If after you have signed this form you have any questions about your privacy rights,
please contact the Yale Privacy Officer at (203) 432-5919.

If you have further questions about this project or if you have a research-related problem,
you may contact the co-Principal Investigator, Elisabeth Mirenda. If you would like to
talk with someone other than the researchers to discuss problems, concerns, and questions
you may have concerning this research, or to discuss your rights as a research subject,
you may contact the Yale Human Investigation Committee at (203) 785-4688.

59

APPENDIX B: SAMPLE PSQI
The Pittsburg Sleep Quality Index (PSQI)
Instructions: The following questions relate to your usual sleep habits during the past
month only. Your answers should indicate the most accurate reply for the majority of
days and nights in the past month. Please answer all questions. During the past month:
1.
2.
3.
4.

When have you usually gone to bed?
How long (in minutes) has it taken you to fall asleep each night?
When have you usually gotten up in the morning?
How many hours of actual sleep do you get at night? (This may be different than
the number of hours you spend in bed)

Choose: Not during the past month (0), Less than once a week (1), Once or twice a week
(2), Three or more times a week (3)
5. During the past month, how often have you had trouble sleeping because you…
a. Cannot get to sleep within 30 minutes
b. Wake up in the middle of the night or early morning
c. Have to get up to use the bathroom
d. Cannot breathe comfortably
e. Cough or snore loudly
f. Felt too cold
g. Felt too hot
h. Have bad dreams
i. Have pain
j. Other reason(s), please describe, including how often you have had trouble
sleeping because of this reason(s):
6. During the past month, how often have you taken medicine (prescribed or “over
the counter”) to help you sleep?
7. During the past month, how often have you had trouble staying awake while
driving, eating meals, or engaging in social activity?
8. During the past month, how much of a problem has it been for you to keep up
enthusiasm to get things done?
Choose: Very good (0), Fairly good (1), Fairly bad (2), Very bad (3)
9. During the past month, how would you rate your sleep quality overall?
Component 1: #9 score_____
Component 2: #2 score (≤15 min=0; 16-30 min=1; 31-60 min=2, >60 min=3) + #5a
score (If sum is equal 0=0; 1-2=1; 3-4=2; 5-6=3) _____
Component 3: #4 Score (>7=0; 6-7=1; 5-6=2; <5=3) ______
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Component 4: (total # of hours asleep)/ (total # of hours in bed) x 100;
>85%=0, 75%-84%=1, 65%-74%=2, <65%=3______
Component 5: Sum of Scores #5b to #5j (0=0; 1-9=1; 10-18=2; 19-27=3) _____
Component 6: #6 score _____
Component 7: #7 score + #8 score (0=0; 1-2=1; 3-4=2; 5-6=3) ______
Add the seven component scores together. Global PSQI Score: ________

Permission has been granted to reproduce, post, download, and/or distribute, this material
in its entirety for not-for-profit educational purposes by the Hartford Institute for
Geriatric Nursing, New York University, College of Nursing.
Buysse, D.J., Reynolds III, C.F., Monk, T.H., Berman, S.R., & Kupfer, D.J. (1989). The
Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and
research. Journal of Psychiatric Research, 28(2), 193-213.
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APPENDIX C: SAMPLE SIZE CALCULATION

Power and Precision Version 4.0 Biostat Inc., Englewood, NJ
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